Innospec earnings were $114.2M for the trailing 12 months ending Mar 31, 2026, with 325.9% growth year over year. The latest IOSP earnings report on Mar 31, 2026 announced Q1 2026 earnings of $30.4M, down 35.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IOSP reported annual earnings of $116.6M, with 227.5% growth.
IOSP past earnings growth
How has IOSP's earnings growth performed historically?
On IOSP's earnings call on Invalid Date, Innospec (NASDAQ: IOSP) reported Q1 2026 earnings per share (EPS) of $1.23, up 6.11% year over year. Total IOSP earnings for the quarter were $30.40 million. In the same quarter last year, Innospec's earnings per share (EPS) was $1.31.
As of the last Innospec earnings report, Innospec is currently profitable. Innospec's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $114.20 million, a 322.96% increase year over year.
What was IOSP's earnings growth in the past year?
As of Innospec's earnings date in Invalid Date, Innospec's earnings has grown 325.93% year over year. This is 318.87 percentage points higher than the US Specialty Chemicals industry earnings growth rate of 7.06%. IOSP earnings in the past year totalled $114.20 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.